In a major development, Moderna has posted an updated protocol for its Phase 3 study of the Moderna COVID-19 Vaccine on December 23.
The protocol reflects inclusion of Amendment 6 from Dec. 23, 2020.
What is in it?The purpose of this amendment is to inform all ongoing study participants of the availability of and eligibility criteria of any COVID-19 vaccine made available under an Emergency Use Authorization (EUA) and to offer participants who originally received placebo in this study the...
https://mfame.guru/moderna-phase-3-vaccine-fulfils-interim-targets-of-95-efficacy/